Anti-GBP1 antibody [EPR8285]
- RabMAb
- Recombinant
- KO Validated
- What is this?
Be the first to review this product! Submit a review
|
(17 Publications)
Rabbit Recombinant Monoclonal GBP1 antibody. Suitable for IHC-P, WB, ICC/IF and reacts with Human samples. Cited in 17 publications.
View Alternative Names
Guanylate-binding protein 1, GTP-binding protein 1, Guanine nucleotide-binding protein 1, Interferon-induced guanylate-binding protein 1, GBP-1, HuGBP-1, hGBP1, GBP1
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-GBP1 antibody [EPR8285] (AB131255)
Immunohistochemical analysis of paraffin embedded Human spleen tissue labelling GBP1 with ab131255 antibody at 1/50 dilution.
Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-GBP1 antibody [EPR8285] (AB131255)
Immunofluorescent analysis of IFN-gamma induced HeLa cells labelling GBP1 with ab131255 antibody at 1/100 dilution.
- WB
Lab
Western blot - Anti-GBP1 antibody [EPR8285] (AB131255)
Lanes 1-4 : Merged signal (red and green). Green - ab131255 observed at 68 kDa. Red - loading control ab8245 observed at 36 kDa.
ab131255 Anti-GBP1 antibody [EPR8285] was shown to specifically react with GBP1 in wild-type A549 cells. Loss of signal was observed when knockout cell line ab267202 (knockout cell lysate ab257960) was used. Wild-type and GBP1 knockout samples were subjected to SDS-PAGE. ab131255 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) were incubated overnight at 4°C at 1 in 1000 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-GBP1 antibody [EPR8285] (ab131255) at 1/1000 dilution
Lane 1:
Wild-type A549 cell lysate at 20 µg
Lane 2:
GBP1 knockout A549 cell lysate at 20 µg
Lane 2:
Western blot - Human GBP1 knockout A549 cell line (<a href='/en-us/products/cell-lines/human-gbp1-knockout-a549-cell-line-ab267202'>ab267202</a>)
Lane 3:
HeLa treated with 10ng/ml IFN-γ for 24 hours, whole cell lysate at 20 µg
Lane 4:
Untreated HeLa cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-irdye-800cw-preadsorbed-ab216773'>ab216773</a>) at 1/10000 dilution
Predicted band size: 68 kDa
Observed band size: 68 kDa
false
- WB
Unknown
Western blot - Anti-GBP1 antibody [EPR8285] (AB131255)
All lanes:
Western blot - Anti-GBP1 antibody [EPR8285] (ab131255) at 1/1000 dilution
Lane 1:
HeLa cell lysate, treated with IFN gamma at 10 µg
Lane 2:
HeLa cell lysate at 10 µg
Secondary
All lanes:
HRP labelled Goat anti Rabbit IgG at 1/2000 dilution
Predicted band size: 68 kDa
false
- OI-RD Scanning
Unknown
OI-RD Scanning - Anti-GBP1 antibody [EPR8285] (AB131255)
We have systematically measured KD (the equilibrium dissociation constant between the antibody and its antigen), of more than 840 recombinant antibodies to assess not only their individual KD values but also to see the average affinity of antibody. Based on the comparison with published literature values for mouse monoclonal antibodies, Recombinant antibodies appear to be on average 1-2 order of magnitude higher affinity.
Related conjugates and formulations (3)
-
Anti-GBP1 antibody [EPR8285] - BSA and Azide free
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-GBP1 antibody [EPR8285]
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-GBP1 antibody [EPR8285]
Reactivity data
Product details
Species reactivity
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species.
Please contact us for more information.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The GBP1 protein supports cellular defense mechanisms against pathogens such as viruses and bacteria. GBP1 participates in the hydrolysis of GTP to GMP an action that influences its anti-pathogenic effects. It is a member of the interferon-inducible large GTPase family and can form oligomeric complexes enhancing its antiviral and antimicrobial activity. It interacts with various proteins linked to innate immunity and contributes to modulating the immune response.
Pathways
GBP1 is involved in pathways linked to interferon signaling and innate immunity. The protein plays a significant role in the JAK-STAT signaling pathway where it exerts its antiviral effects. GBP1 interacts closely with other proteins such as STAT1 and is responsive to interferon signals influencing gene expression and immune responses. Its activity in these pathways is critical for mounting an effective defense against infections.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (17)
Recent publications for all applications. Explore the full list and refine your search
Breast cancer research : BCR 27:162 PubMed40999477
2025
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in oncology 15:1434249 PubMed40018406
2025
Applications
Unspecified application
Species
Unspecified reactive species
Immunity 57:1812-1827.e7 PubMed38955184
2024
Applications
Unspecified application
Species
Unspecified reactive species
Journal of medical virology 96:e29730 PubMed38860570
2024
Applications
Unspecified application
Species
Unspecified reactive species
mBio 14:e0170723 PubMed37737612
2023
Applications
Unspecified application
Species
Unspecified reactive species
Pathogens and disease 81: PubMed37012222
2023
Applications
Unspecified application
Species
Unspecified reactive species
mBio 13:e0188822 PubMed36154443
2022
Applications
Unspecified application
Species
Unspecified reactive species
The journal of obstetrics and gynaecology research 47:3913-3922 PubMed34482592
2021
Applications
Unspecified application
Species
Unspecified reactive species
mBio 12:e0205421 PubMed34399626
2021
Applications
Unspecified application
Species
Unspecified reactive species
Journal of immunology (Baltimore, Md. : 1950) 207:555-568 PubMed34233910
2021
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com